Sucraid

Active Ingredient(s): Sacrosidase
FDA Approved: * April 9, 1998
Pharm Company: * QOL MEDCL
Category: Gastrointestinal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Sucraid Overview

Sacrosidase (trade name Sucraid) is a medication used to replace sucrase in people lacking this enzyme.[1] It is available as an oral solution. Sucraid is approved by the U.S. Food and Drug Administration (FDA) for the therapy of the genetically determined sucrase deficiency that is part of the Congenital Sucrase-Isomaltase Deficiency (CSID). Sucraid assists in the breakdown of sugar/sucrose into simpler forms. Many uses for Sucraid include the relief of gastrointestinal symp...

Read more Sucraid Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sucraid

Recent Sucraid Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sacrosidase

Solution: 8,500 iu/ml, 8500IU/ml

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Sucraid: (1 result)

Sorted by National Drug Code

67871-111 Sucraid 8500 [iu]/Ml Oral Solution by Qol Medical, LLC

Other drugs which contain Sacrosidase or a similar ingredient: (1 result)

SACROSIDASE